Sandra Ramirez, General Manager of Bristol-Myers Squibb Colombia & Mexico, reveals valuable insights into the long-standing presence of BMS in Colombia, marked by a continuous dedication to increase access to medicine, the gradual development of their immuno-oncology pipeline and the creation of an inclusive culture formed by satisfied employees.
Ms. Ramirez, you are in charge of BMS operations in both Colombia and Mexico. What are some of the main differences that you have observed between these two markets?
"In our 69 years in this market, we have managed to establish a leading position in the areas of cancer treatment, immunology, hepatitis C and virology"
